Gemina Laboratories Ltd (QB) (GLABF)
USOTC
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End January 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Return on Assets (%) | -66.007 | -239.929 | -362.914 | -313.179 |
| Return on Equity (%) | -1042.5 | -857.79 | -1371.33 | 629.572 |
| Return on Invested Capital (%) | -1103.797 | -853.159 | 2960.104 | 238.237 |
| Operating Margin (%) | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A |
| Book Value Per Share | 0.004 | 0.017 | -0.001 | -0.022 |
| Earnings Per Share | -0.022 | -0.085 | -0.091 | -0.071 |
| Cash Per Share | 0.023 | 0.021 | 0.001 | N/A |
| Working Capital Per Share | 0.003 | 0.016 | -0.018 | -0.037 |
| Operating Profit Per Share | N/A | 0.004 | N/A | N/A |
| EBIT Per Share | -0.022 | -0.085 | -0.091 | -0.071 |
| EBITDA Per Share | -0.022 | -0.085 | -0.091 | -0.071 |
| Free Cash Flow Per Share | -0.022 | -0.086 | -0.09 | -0.072 |
| Year End January 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
| Shares Outstanding | 38.47M | 55.6M | 65.85M | 73.33M |
| Market Cap | 29.62M |
| Price to Earnings Ratio | -5.72 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -18.82 |
| Dividend Yield | - |
| Shares Outstanding | 74.57M |
| Average Volume (1 week) | 2.5k |
| Average Volume (1 Month) | 2.5k |
| 52 Week Change | -0.70% |
| 52 Week High | 0.6504 |
| 52 Week Low | 0.235 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
